RPL9 and pancreatic neoplasm: That is, this may suggest that the splicing of RPL9 might alter the UPF3A-mediated NMD of NR3C2. In addition, NR3C2 was recently revealed to be a potential tumor-suppressor gene in pancreatic cancer.